BPH Global

BPH Global Current Assets

The Current Assets of BPH Global (BP8.AX) as of Oct 30, 2026 is 533,236.00 AUD. In the previous year, Current Assets was 538,806.00 AUD — a change of -1.03% (lower).

Current Assets

533,236.00AUD

YoY

-1.03%

Last updated:

Current Assets of BPH Global is 2026 533,236.00 AUD. Current Assets of BPH Global was 2025 538,806.00 AUD. It decreases by -1.03% lower compared to the previous year.

The BPH Global Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
2.18 M AUD
Jan 1, 2020
866,831.00 AUD
Jan 1, 2021
8.79 M AUD
Jan 1, 2022
5.50 M AUD
Jan 1, 2023
1.26 M AUD
Jan 1, 2024
284,715.00 AUD
Jan 1, 2025
538,806.00 AUD
Jan 1, 2026
533,236.00 AUD
The BPH Global Current Assets history
YEARCurrent AssetsYoY
533,236.00AUD-1.03%
538,806.00AUD+89.24%
284,715.00AUD-77.41%
1.26 MAUD-77.08%
5.50 MAUD-37.42%
8.79 MAUD+913.57%
866,831.00AUD-60.15%
2.18 MAUD+52.11%
1.43 MAUD+37.16%
1.04 MAUD+179.58%
372,897.00AUD-89.51%
3.55 MAUD—
0.00AUD-100.00%
148.49 MAUD+61.80%
91.77 MAUD+58.63%
57.85 MAUD+43.80%
40.23 MAUD+73.02%
23.25 MAUD+332.47%
5.38 MAUD-1.41%
5.45 MAUD+81.71%
3.00 MAUD-16.65%
3.60 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BPH Global Stock analysis

What does BPH Global do? BPH Global Ltd. makes money by developing and commercializing plant-based products derived from stem cell technology, focusing on Traditional Chinese Medicine health outcomes. The company produces foods, nutraceuticals, and pharmaceutical ingredients using plants like Caulerpa lentillifera, Dendrobium officinale, Resina, and Cannabis sativa. Its products include sustainable plant-based protein foods, CBD from Hemp, and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. Key markets are Singapore, Australia, Southeast Asia, and China, with subsidiaries operating in these regions. The firm's revenue streams come from selling plant-based protein foods, nutraceutical and pharmaceutical ingredients, and CBD products. Subsidiaries such as Stemcell United Pte Ltd and SCU Southeast Asia Sdn Bhd handle production and distribution in target markets. Products are utilized by companies in food, healthcare, cosmetics, and personal care sectors, leveraging Traditional Chinese Medicine principles for health outcomes. BPH Global Ltd. targets consumers and businesses seeking natural health solutions through plant-based ingredients. Its focus on sustainable protein and CBD aligns with growing demand in food and wellness industries. The company's subsidiaries in Singapore, Australia, Southeast Asia, and China support regional market penetration and product customization for local preferences. BPH Global is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BPH Global stock

Current Assets of BPH Global is 533,236.00 AUD in 2026.

Current Assets of BPH Global changed from 538,806.00 AUD to 533,236.00 AUD, representing a -1.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets BPH Global since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's BPH Global historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — BPH Global

All Key Metrics — BPH Global